Radiopharm Theranostics Limited (AU:RAD) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Radiopharm Theranostics Limited has successfully listed its American Depositary Shares on the Nasdaq Capital Market under the ticker symbol ‘RADX’, marking a significant strategic milestone. This secondary listing aims to enhance the company’s visibility among U.S. and international investors without any associated capital raising. Existing U.S. shareholders currently hold 21% of Radiopharm, and the company continues its focus on developing innovative radiopharmaceuticals for oncology.
For further insights into AU:RAD stock, check out TipRanks’ Stock Analysis page.